LifeStance Health Group (LFST) News Today

LifeStance Health Group, Inc. (NASDAQ:LFST - Get Free Report) has been assigned an average rating of "Hold" from the six ratings firms that are covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation

Principal Financial Group Inc. decreased its holdings in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 2.0% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 3,881,450 shares of the company's stock after selling 79,501 shar

LifeStance Health Group, Inc. (NASDAQ:LFST - Get Free Report) was the recipient of a significant drop in short interest during the month of August. As of August 15th, there was short interest totalling 12,220,000 shares, a drop of 17.8% from the July 31st total of 14,870,000 shares. Currently, 11.0% of the shares of the company are short sold. Based on an average trading volume of 1,900,000 shares, the short-interest ratio is presently 6.4 days.

LifeStance Health Group, Inc. (NASDAQ:LFST - Get Free Report) insider Ann Varanakis sold 5,269 shares of the business's stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $6.28, for a total value of $33,089.32. Following the transaction, the insider now owns 263,007 shares in the company, valued at $1,651,683.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

LifeStance Health Group (NASDAQ:LFST) Shares Gap Up to $6.18

LifeStance Health Group, Inc. (NASDAQ:LFST - Get Free Report) was the target of some unusual options trading activity on Monday. Investors acquired 3,293 call options on the company. This represents an increase of 655% compared to the average daily volume of 436 call options.

LifeStance Health Group (NASDAQ:LFST) Stock Price Up 5%

LifeStance Health Group, Inc. (NASDAQ:LFST - Get Free Report) saw a significant decrease in short interest in the month of July. As of July 31st, there was short interest totalling 14,870,000 shares, a decrease of 5.9% from the July 15th total of 15,810,000 shares. Currently, 13.4% of the shares of the stock are short sold. Based on an average trading volume of 1,860,000 shares, the short-interest ratio is currently 8.0 days.

Shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Get Free Report) have received a consensus recommendation of "Hold" from the six brokerages that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, three have issued a h

UBS Group reduced their target price on LifeStance Health Group from $9.00 to $7.50 and set a "neutral" rating for the company in a report on Thursday.

LifeStance Health Group (NASDAQ:LFST - Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.06) earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.01. The company had revenue of $312.30 million for the quarter, compared to analyst estimates of $305.85 million. LifeStance Health Group had a negative net margin of 15.69% and a negative return on equity of 11.92%. LifeStance Health Group's revenue for the quarter was up 20.3% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.13) EPS.

LifeStance Health Group (NASDAQ:LFST) Shares Gap Down After Analyst Downgrade

Barclays dropped their price objective on shares of LifeStance Health Group from $8.00 to $6.00 and set an "underweight" rating for the company in a research note on Friday.

LifeStance Health Group (NASDAQ:LFST) Trading 10.9% Higher

Vanguard Group Inc. increased its holdings in shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 1.3% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 7,668,966 shares of the company's stock afte

LifeStance Health Group (NASDAQ:LFST) will be releasing earnings before the market opens on Thursday, August 8, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=420428)

LifeStance Health Group (NASDAQ:LFST) Shares Gap Up to $5.50

LifeStance Health Group (NASDAQ:LFST) Sees Unusually-High Trading Volume

O Brien Wealth Partners LLC lowered its holdings in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 24.9% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 537,901 shares of the company's stock after selling 178,2

LifeStance Health Group (NASDAQ:LFST) Sets New 1-Year Low at $4.69

LifeStance Health Group (NASDAQ:LFST) Trading Down 4.9%

LifeStance Health Group, Inc. (NASDAQ:LFST - Get Free Report) insider Danish J. Qureshi sold 150,000 shares of the stock in a transaction on Friday, June 14th. The shares were sold at an average price of $5.21, for a total transaction of $781,500.00. Following the transaction, the insider now directly owns 439,002 shares in the company, valued at $2,287,200.42. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

LifeStance Health Group, Inc. (NASDAQ:LFST - Get Free Report) insider Kevin Michael Mullins sold 85,093 shares of the stock in a transaction dated Tuesday, June 11th. The stock was sold at an average price of $5.53, for a total transaction of $470,564.29. Following the completion of the transaction, the insider now owns 4,650,571 shares of the company's stock, valued at $25,717,657.63. The sale was disclosed in a document filed with the SEC, which is available through this link.

LifeStance Health Group (NASDAQ:LFST) Stock Price Down 5.1%

LifeStance Health Group, Inc. (NASDAQ:LFST - Get Free Report) major shareholder Summit Partners Growth Equity sold 3,802,345 shares of the company's stock in a transaction on Friday, May 24th. The shares were sold at an average price of $5.89, for a total value of $22,395,812.05. Following the transaction, the insider now directly owns 41,932,358 shares in the company, valued at $246,981,588.62. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Major shareholders that own more than 10% of a company's stock are required to disclose their transactions with the SEC.